Publications by authors named "P Caciagli"
Objectives: To report the resistance rate against fosfomycin trometamol among outpatient women with symptoms related to urinary tract infections over a 6-year period in a multicentre, cross-sectional study.
Methods: Urinary samples were collected from three high-volume laboratories from January 2015 to December 2020. The pattern of resistance to fosfomycin was analysed by using the Vitek II automated system.
Article Synopsis
- Efficient testing for SARS-CoV-2 is essential for tracking infections in communities, with traditional nasopharyngeal swabs being the gold standard for diagnosis.
- A new saliva collection device was tested against nasopharyngeal swabs, showing a moderate concordance of 68%, although neither method identified all infections.
- The saliva test was found to be particularly effective for asymptomatic individuals and valuable for contact tracing, suggesting it could be a reliable option for community-wide COVID-19 screening.
Introduction: The rubella test during pregnancy makes it possible to identify situations at risk of congenital rubella and those pregnant mothers who should be offered the MMR vaccine.
Materials And Methods: The Authors analysed test coverage and the immunity status of pregnant mothers between 2005 and 2017, using birth attendance certificates.
Results: Rubella test coverage on 61,437 pregnant mothers was 99.
Background: Peri-implant mucositis and peri-implantitis are biofilm-related diseases causing major concern in oral implantology, requiring complex anti-infective procedures or implant removal. Microbial biosurfactants emerged as new anti-biofilm agents for coating implantable devices preserving biocompatibility. This study aimed to assess the efficacy of rhamnolipid biosurfactant R89 (R89BS) to reduce Staphylococcus aureus and Staphylococcus epidermidis biofilm formation on titanium.
View Article and Find Full Text PDFMicrobial biofilms strongly resist host immune responses and antimicrobial treatments and are frequently responsible for chronic infections in peri-implant tissues. Biosurfactants (BSs) have recently gained prominence as a new generation of anti-adhesive and antimicrobial agents with great biocompatibility and were recently suggested for coating implantable materials in order to improve their anti-biofilm properties. In this study, the anti-biofilm activity of lipopeptide AC7BS, rhamnolipid R89BS, and sophorolipid SL18 was evaluated against clinically relevant fungal/bacterial dual-species biofilms (, , ) through quantitative and qualitative tests.
View Article and Find Full Text PDF